Clinical Trial Update: A Clinical Trial Comparing Short-Term Efficacy and Safety of Exubera and Lantus [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial comparing the short-term efficacy and safety of Exubera and Lantus in adults with Type 2 diabetes has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Exubera (insulin inhalation powder)
• Lantus (insulin glargine)

Snippet

Sponsor: Pfizer | Conditions: Diabetes Mellitus, Type 2 | Phase 4 | Status: COMPLETED